Interestingly, TET2-deficient mouse models demonstrated that inflammation via the NLRP3 inflammasome and calcium handling abnormalities in atrial cells contributed to AF susceptibility, findings that were further proved by the decreased arrhythmia incidence after NLRP3 inhibition [74]. The gene discussed is TET2; the disease is atrial fibrillation.